Insiders · Profile

ENGLEMAN EDGAR

Director at Bolt Biotherapeutics. Filing since 9 Feb 2021. CIK 0001227162

Company
Date
Role
Action
Shares
Amount
Of holding
30 Nov 2023
Director
Sold at will
123,079
$105.61K
32.9%
29 Nov 2023
Director
Sold at will
25,805
$23.38K
8.8%
21 Nov 2023
Director
Sold at will
1,943
$1.75K
0.7%
20 Nov 2023
Director
Sold at will
31,257
$28.76K
10.4%
17 Nov 2023
Director
Sold at will
9,345
$8.69K
3.3%
16 Nov 2023
Director
Sold at will
8,571
$8.23K
3.0%
9 Feb 2021
Director
Bought
175,733
$3.51M
9.6%
9 Feb 2021
Director
Bought
24,267
$485.34K
9.6%
9 Feb 2021
Director
Sold, plan not stated
144
$2.88K
0.0%
9 Feb 2021
Director
Sold, plan not stated
20
$400.00
0.0%
10 decisions on file.